NEW YORK AP – Biotechnology giant Genentech Inc. rejected a $43.7 billion buyout offer from its majority owner Roche on Wednesday but said it is open to a higher takeover bid.
The rejection comes nearly a month after Swiss drug developer Roche offered $89 per share for the rest of South San Francisco, Calif.-based Genentech. Roche already owns about 55.9 percent of the company.